Schloetelburg, Wiebke http://orcid.org/0000-0001-9685-0947
Hartrampf, Philipp E.
Kosmala, Aleksander
Serfling, Sebastian E.
Dreher, Niklas
Schirbel, Andreas
Fassnacht, Martin
Buck, Andreas K.
Werner, Rudolf A.
Hahner, Stefanie
Funding for this research was provided by:
Universitätsklinikum Würzburg
Article History
Received: 19 January 2024
Accepted: 10 June 2024
First Online: 19 June 2024
Declarations
:
: The study was conducted according to the guidelines of the Declaration of Helsinki. Ethical review and approval were waived for this study by the local Ethics Committee due to the retrospective character of the study (no. 20210726 02).
: All procedures have been conducted as part of clinical routine care. Informed consent has been obtained from all subjects.
: RAW and AKB have received speaker honoraria from Novartis/AAA and PentixaPharm. RAW reports advisory board work for Novartis/AAA and Bayer. AKB is a member of the advisory board of PentixaPharm. All other authors declare no conflict of interest.